Placeholder canvas

Zydus Cadila, First Indian Company Gets Permission For Clinical Trials Of Antibodies Cocktail To Treat COVID-19: Sources

Date:

The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of COVID-19 has been given permission to conduct clinical trials by the Subject Expert Committee (SEC) of Central Drugs Standard Control Organisation (CDSCO), according to sources.

“SEC gives a recommendation for the Phase I and II clinical trials of Zydus Cadila’s biological therapy ZRC-3308, a cocktail of two SARS-CoV-2-neutralising monoclonal antibodies (mAbs) that can emerge as one of the main treatments for mild COVID-19,” the sources said.

These antibodies are made by cloning unique white blood cells. Domestic pharmaceutical major Zydus Cadila has sought the Drug Controller General of India (DCGI) permission recently to undertake clinical trials.

Zydus said that its biological therapy ZRC-3308, a cocktail of two SARS-CoV-2-neutralising monoclonal antibodies (mAbs) can emerge as one of the main treatments for mild COVID-19.

Also Read: India To Be Key Part Of Biden’s Allocation Plan Of 25 Million COVID-19 Vaccines: Envoy Sandhu

Currently, some of the hospitals are administering the cocktail of two fast-acting anti-bodies – Casirivimab and Imdevimab, the batch of the Roche Antibody Cocktail drug arrived in the country on May 24. The cost of a single antibody cockatail is Rs 59,750.

Another antibody cocktail that has received permission is Eli Lilly and Company, India announced that it has received permission for restricted emergency use of its antibody drugs, bamlanivimab 700mg and etesevimab 1400mg, in India for the treatment of patients with mild to moderate coronavirus disease 2019.

(With ANI Inputs)

Click here for Latest News updates and viral videos on our AI-powered smart news

For viral videos and Latest trends subscribe to NewsMobile YouTube Channel and Follow us on Instagram

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

Popular

More like this
Related

H1B Visa: USCIS Gears Up For Lottery Selection For Fy-25

Due to a technical issue with its website, the USCIS delayed the deadline for visa applications for the financial year 2025 by three days from March 22nd to March 25th, 2024

To Browbeat And Bully Others Is Vintage Congress Culture: PM Modi After 600 Lawyers Write CJI

New Delhi: In response to the voiced apprehensions of...

Allu Arjun’s ‘Pushpa’ Saga: Trilogy Confirmed with ‘The Roar’ Title

As the dust settles from the electrifying release of...

IPL 2024: Delhi Capitals Win Toss, Opt to Bowl First Against Rajasthan Royals

Jaipur: Delhi Capitals (DC) skipper Rishabh Pant won the...